<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>LGR5, known as a target of Wnt signaling, has been reported as an intestinal stem cell marker </plain></SENT>
<SENT sid="1" pm="."><plain>Recent reports showed that LGR5 was associated with <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>CD44 is a ubiquitously expressed cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule and also a potential cell surface marker on <z:hpo ids='HP_0003003'>colon cancer</z:hpo> stem cells </plain></SENT>
<SENT sid="3" pm="."><plain>Both LGR5 and CD44 have been also reported to be Wnt signal targets </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of this study was to investigate the association of these markers with clinical outcome in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> after preoperative chemoradiotherapy (CRT) </plain></SENT>
<SENT sid="5" pm="."><plain>A total of 52 rectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> specimens were obtained from patients who underwent preoperative CRT </plain></SENT>
<SENT sid="6" pm="."><plain>We performed transcriptional and immunohistochemical analyses, and retrospectively studied the association of LGR5 and CD44 expression levels with clinical outcomes </plain></SENT>
<SENT sid="7" pm="."><plain>For CD44, its expression in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stroma was also evaluated </plain></SENT>
<SENT sid="8" pm="."><plain>The levels of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> LGR5 and CD44 gene expression were significantly and positively correlated </plain></SENT>
<SENT sid="9" pm="."><plain>LGR5 gene expression level in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and positivity of CD44 gene expression in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stroma were significantly correlated with disease recurrence </plain></SENT>
<SENT sid="10" pm="."><plain>Elevated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> LGR5 gene expression and positive CD44 gene expression in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stroma were significantly associated with poor recurrence-free and overall survival </plain></SENT>
<SENT sid="11" pm="."><plain>Multivariate analysis indicated that positivity of stromal CD44 gene expression was an independent prognostic factor for the recurrence and overall survival of patients with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> after preoperative CRT </plain></SENT>
<SENT sid="12" pm="."><plain>In conclusion, LGR5 and CD44 expression may be coordinately associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> relapse in locally advanced <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> after preoperative CRT </plain></SENT>
</text></document>